journal
MENU ▼
Read by QxMD icon Read
search

Journal of Gynecologic Oncology

journal
https://www.readbyqxmd.com/read/29400024/e2-e6-ratio-and-l1-immunoreactivity-as-biomarkers-to-determine-hpv16-positive-high-grade-squamous-intraepithelial-lesions-cin2-and-3-and-cervical-squamous-cell-carcinoma
#1
Youn Jin Choi, Ahwon Lee, Tae Jung Kim, Hyun Tak Jin, Yong Bok Seo, Jong Sup Park, Sung Jong Lee
OBJECTIVE: Human papillomavirus (HPV) 16 is the most carcinogenic HPV genotype. We investigated if HPV16 L1 capsid protein and E2/E6 ratio, evaluated by cervical cytology, may be used as biomarkers of ≥cervical intraepithelial neoplasia (CIN) 2 lesions. METHODS: Cervical specimens were obtained from 226 patients with HPV16 single infection. Using cytology specimen, L1 capsid protein and E2/E6 ratio were detected and the results were compared with those of the conventional histologic analysis of cervical tissues (CIN1-3 and squamous cell carcinoma [SCC]) to evaluate the association...
February 1, 2018: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29400023/diagnostic-value-of-integrated-%C3%A2-%C3%A2-f-fluoro-2-deoxyglucose-positron-emission-tomography-computed-tomography-in-recurrent-epithelial-ovarian-cancer-accuracy-of-patient-selection-for-secondary-cytoreduction-in-134-patients
#2
Young Jae Lee, Yong Man Kim, Phill Seung Jung, Jong Jin Lee, Jeong Kon Kim, Young Tak Kim, Joo Hyun Nam
OBJECTIVE: The aim of this study was to evaluate the diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose-positron emission tomography/computed tomography (¹⁸F-FDG-PET/CT) for suspected recurrence of epithelial ovarian cancer (EOC) with non-disseminated lesions. METHODS: We retrospectively reviewed the medical records of recurrent EOC patients who underwent secondary cytoreduction from January 2000 to December 2013. A total of 134 patients underwent secondary cytoreduction after imaging with either ¹⁸F-FDG-PET/CT or contrast-enhanced computed tomography (CECT)...
February 1, 2018: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29400021/risk-factors-in-progression-from-endometriosis-to-ovarian-cancer-a-cohort-study-based-on-medical-insurance-data
#3
An Jen Chiang, Chung Chang, Chi Hsiang Huang, Wei Chun Huang, Yuen Yee Kan, Jiabin Chen
OBJECTIVE: The objective was to identify risk factors that were associated with the progression from endometriosis to ovarian cancer based on medical insurance data. METHODS: The study was performed on a dataset obtained from the National Health Insurance Research Database, which covered all the inpatient claim data from 2000 to 2013 in Taiwan. The International Classification of Diseases (ICD) code 617 was used to screen the dataset for the patients who were admitted to hospital due to endometriosis...
February 1, 2018: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29400022/screening-for-lynch-syndrome-using-risk-assessment-criteria-in-patients-with-ovarian-cancer
#4
Takashi Takeda, Kosuke Tsuji, Kouji Banno, Megumi Yanokura, Yusuke Kobayashi, Eiichiro Tominaga, Daisuke Aoki
OBJECTIVE: Lynch syndrome is a cancer predisposition syndrome caused by germline mutation of DNA mismatch repair (MMR) genes. Lynch syndrome only causes about 0.4% of cases of ovarian cancer, which suggests that universal screening may not be cost-efficient. However, the frequency of Lynch syndrome in ovarian cancer is unclear in the Asian population. The goal of the study was to investigate a screening strategy using family history. METHODS: The subjects were 129 patients with ovarian cancer...
January 30, 2018: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29400020/programmed-death-1-pd-1-expression-in-cervical-intraepithelial-neoplasia-and-its-relationship-with-recurrence-after-conization
#5
Hyeyoon Chang, Jin Hwa Hong, Jae Kwan Lee, Hyun Woong Cho, Yung Taek Ouh, Kyung Jin Min, Kyeong A So
OBJECTIVE: Impaired local cellular immunity contributes to persistent human papillomavirus (HPV) infection and development of cervical intraepithelial neoplasia (CIN). Programmed death-1 (PD-1) and its ligands PD-ligand-1 (L1) and PD-L2 are negative regulators of T cell activity in various cancers, but few studies exist. The aim of this study was to determine the clinicopathologic and immunologic parameters (PD-1, PD-L1, and PD-L2) related to the persistence/recurrence of CIN after conization...
January 29, 2018: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29400018/impact-of-adjuvant-hysterectomy-on-prognosis-in-patients-with-locally-advanced-cervical-cancer-treated-with-concurrent-chemoradiotherapy-a-meta-analysis
#6
Seung Hyuk Shim, Soo Nyung Kim, Su Hyun Chae, Jung Eun Kim, Sun Joo Lee
OBJECTIVE: Few data exist regarding adjuvant hysterectomy (AH) in locally advanced cervical cancer (LACC) patients treated with chemoradiotherapy. We investigated the effect of AH on prognosis in LACC patients, through meta-analysis. METHODS: EMBASE and MEDLINE databases and the Cochrane Library were searched for published studies comparing LACC patients who received AH after chemoradiotherapy with those who did not, through April 2016. Endpoints were mortality and recurrence rates...
January 5, 2018: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29400015/trends-of-uterine-carcinosarcoma-in-the-united-states
#7
Koji Matsuo, Malcolm S Ross, Hiroko Machida, Erin A Blake, Lynda D Roman
OBJECTIVE: Uterine carcinosarcoma (UCS) is a rare type of high-grade endometrial cancer (EC) that has been understudied with population-based statistics due to its rarity. This study examined temporal trends in the proportion of UCS among women with EC. METHODS: This is a retrospective observational study examining The Surveillance, Epidemiology, and End Results program between 1973-2013. Primary EC cases were eligible for analysis, and a time-specific proportion of UCS was examined during the study period...
January 5, 2018: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29400019/what-mri-features-suspect-malignant-pure-mesenchymal-uterine-tumors-rather-than-uterine-leiomyoma-with-cystic-degeneration
#8
Tae Hyung Kim, Jae Weon Kim, Sang Youn Kim, Seung Hyup Kim, Jeong Yeon Cho
OBJECTIVE: To retrospectively assess conventional magnetic resonance imaging (MRI) features that differentiate malignant pure mesenchymal uterine tumors (MPMUT); endometrial stromal sarcoma (ESS) and leiomyosarcoma (LMS) from uterine leiomyoma with cystic degeneration (ULCD). METHODS: We retrospectively reviewed magnetic resonance (MR) images of 30 patients with ULCD, 18 with ESS, and 15 with LMS, to assess tumor location, margin, T2 signal intensity (SI), speckled appearance, and peripheral band using univariate and multivariate analyses...
January 4, 2018: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29400014/is-repeated-high-dose-medroxyprogesterone-acetate-mpa-therapy-permissible-for-patients-with-early-stage-endometrial-cancer-or-atypical-endometrial-hyperplasia-who-desire-preserving-fertility
#9
Wataru Yamagami, Nobuyuki Susumu, Takeshi Makabe, Kensuke Sakai, Hiroyuki Nomura, Fumio Kataoka, Akira Hirasawa, Kouji Banno, Daisuke Aoki
OBJECTIVE: Reports on the repeated administration of medroxyprogesterone acetate (MPA) for intrauterine recurrence after fertility-preserving therapy for atypical endometrial hyperplasia (AEH) and early grade 1 endometrioid carcinoma (G1) are lacking. We aimed to clarify the outcomes of repeated MPA therapy in cases of intrauterine recurrence after fertility-preserving therapy with MPA against AEH/early G1. METHODS: Patients with AEH or stage IA well-differentiated endometrioid carcinoma without myometrial invasion who underwent first-line MPA therapy for primary lesions or intrauterine recurrence were divided into initial treatment and repeated treatment groups (162 and 82 patients, respectively)...
January 2, 2018: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29400017/trends-in-single-women-with-malignancy-of-the-uterine-cervix-in-united-states
#10
Hiroko Machida, Erin A Blake, Sarah E Eckhardt, Tsuyoshi Takiuchi, Brendan H Grubbs, Mikio Mikami, Lynda D Roman, Koji Matsuo
OBJECTIVE: To examine trends and characteristics of single women with malignancy of the uterine cervix. METHODS: This is a retrospective observational study examining the United States population-based tumor registry (the Surveillance, Epidemiology, and End Results program). Time-specific trends in single marital status were examined in 3,294,208 women among 12 common female malignancies including 87,151 women with uterine cervical malignancy between 1973 and 2013...
December 27, 2017: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29400016/impact-of-institutional-accreditation-by-the-japan-society-of-gynecologic-oncology-on-the-treatment-and-survival-of-women-with-cervical-cancer
#11
Mikio Mikami, Masako Shida, Takeo Shibata, Hidetaka Katabuchi, Junzo Kigawa, Daisuke Aoki, Nobuo Yaegashi
OBJECTIVE: The Japan Society of Gynecologic Oncology (JSGO) initiated a nation-wide training system for the education and certification for gynecologic oncologists in 2005. To assess the impact of the quality of the JSGO-accredited institutions, JSGO undertook an analysis of the Uterine Cervical Cancer Registry of the Japan Society of Obstetrics and Gynecology (JSOG) to determine the effectiveness of the JSGO-accredited institutions on the treatment and survival of women with cervical cancer...
December 27, 2017: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29400013/seromucinous-component-in-endometrioid-endometrial-carcinoma-as-a-histological-predictor-of-prognosis
#12
Morikazu Miyamoto, Masashi Takano, Tadashi Aoyama, Hiroaki Soyama, Tomoyuki Yoshikawa, Hitoshi Tsuda, Kenichi Furuya
OBJECTIVE: In 2014 World Health Organization criteria, seromucinous carcinoma was defined as a new histological subtype in ovarian carcinomas, but "seromucinous carcinoma" was not defined in endometrial carcinomas. The aim of this study was to identify seromucinous carcinoma resembling ovarian seromucinous carcinoma in endometrial carcinomas, and to evaluate the clinical significance for prognoses of the patients. METHODS: Central pathological review was conducted for patients with endometrioid carcinoma of the endometrium treated by primary surgery at our hospital between 1990 and 2013...
December 22, 2017: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29400012/therapeutic-significance-of-full-lymphadenectomy-in-early-stage-ovarian-clear-cell-carcinoma
#13
Hiroyuki Yamazaki, Yukiharu Todo, Chisa Shimada, Sho Takeshita, Shinichiro Minobe, Kazuhira Okamoto, Katsushige Yamashiro, Hidenori Kato
OBJECTIVES: This study evaluated the therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma (OCCC). METHODS: We retrospectively reviewed records of 127 consecutive patients with pT1/pT2 and M0 OCCC who were treated between January 1995 and December 2015. We compared survival outcomes between those who did and did not undergo para-aortic lymph node dissection (PAND), and analyzed independent prognostic factors (Cox proportional hazards model with backward stepwise elimination)...
December 11, 2017: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29400011/clinical-outcomes-of-patients-with-clear-cell-and-endometrioid-ovarian-cancer-arising-from-endometriosis
#14
E Sun Paik, Tae Joong Kim, Chel Hun Choi, Byoung Gie Kim, Duk Soo Bae, Jeong Won Lee
OBJECTIVE: The aim of this investigation is to compare outcomes of patients according to the presence of cancer arising from endometriosis in ovarian clear cell carcinoma (CCC) and endometrioid carcinoma (EC). METHODS: This study retrospectively investigated 224 CCC and EC patients treated in Samsung Medical Center from 2001 to 2015 to identify cancer arising from endometriosis according to Sampson and Scott criteria. Propensity score matching was performed to compare patients arising from endometriosis to patients without endometriosis (ratio 1:1) according to stage, age, lymph node metastasis (LNM), cancer antigen (CA)-125 level, and residual status after debulking surgery...
December 11, 2017: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29468857/the-5th-biennial-meeting-of-the-asian-society-of-gynecologic-oncology-november-30th-to-december-2nd-2017
#15
Eiichiro Tominaga, Yusuke Kobayashi, Daisuke Aoki
No abstract text is available yet for this article.
March 2018: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29468856/chemoresistance-in-ovarian-cancer-exploiting-cancer-stem-cell-metabolism
#16
REVIEW
Shan Shan Li, Jing Ma, Alice S T Wong
Ovarian cancer is most deadly gynecologic malignancies worldwide. Chemotherapy is the mainstay treatment for ovarian cancer. Despite the initial response is promising, frequent recurrence in patients with advanced diseases remains a therapeutic challenge. Thus, understanding the biology of chemoresistance is of great importance to overcome this challenge and will conceivably benefit the survival of ovarian cancer patients. Although mechanisms underlying the development of chemoresistance are still ambiguous, accumulating evidence has supported an integral role of cancer stem cells (CSCs) in recurrence following chemotherapy...
March 2018: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29468855/major-clinical-research-advances-in-gynecologic-cancer-in-2017
#17
REVIEW
Dong Hoon Suh, Miseon Kim, Kyung Hun Lee, Keun Yong Eom, Maj Kamille Kjeldsen, Mansoor Raza Mirza, Jae Weon Kim
In 2017, 10 topics were selected as major clinical research advances in gynecologic oncology. For cervical cancer, efficacy and safety analysis results of a 9-valent human papillomavirus (HPV) vaccine and long-term impact of reduced dose of quadrivalent vaccine were updated. Brief introduction of KEYNOTE trials of pembrolizumab, a monoclonal antibody that blocks the interaction between programmed death (PD)-1 and its ligands, PD-L1 and PD-L2, followed. Tailored surveillance programs for gynecologic cancer related with Lynch syndrome and update on sentinel lymph node mapping were reviewed for uterine corpus cancer...
March 2018: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29185275/the-feasibility-of-detecting-endometrial-and-ovarian-cancer-using-dna-methylation-biomarkers-in-cervical-scrapings
#18
Cheng Chang Chang, Hui Chen Wang, Yu Ping Liao, Yu Chih Chen, Yu Chun Weng, Mu Hsien Yu, Hung Cheng Lai
OBJECTIVE: We hypothesized that DNA methylation of development-related genes may occur in endometrial cancer (EC)/ovarian cancer (OC) and may be detected in cervical scrapings. METHODS: We tested methylation status by quantitative methylation-specific polymerase chain reaction for 14 genes in DNA pools of endometrial and OC tissues. Tissues of EC/normal endometrium, OC/normal ovary, were verified in training set using cervical scrapings of 10 EC/10 OC patients and 10 controls, and further validated in the testing set using independent cervical scrapings in 30 EC/30 OC patients and 30 controls...
January 2018: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29185274/survival-benefit-of-patients-with-early-stage-ovarian-carcinoma-treated-with-paclitaxel-chemotherapeutic-regimens
#19
Chien An Chen, Chun Ju Chiang, Yun Yuan Chen, San Lin You, Shu Feng Hsieh, Chao Hsiun Tang, Wen Fang Cheng
OBJECTIVE: Adjuvant chemotherapy was introduced in patients with early-stage ovarian cancer (OC). The benefit of standard chemotherapeutic regimens including taxane has not been established. METHODS: Patients with early-stage OC from the National Health Insurance Research database of Taiwan who received platinum plus cyclophosphamide (CP) or platinum plus paclitaxel (PT) for 3-6 cycles were recruited, and the disease-free survival (DFS) and overall survival (OS) were determined...
January 2018: Journal of Gynecologic Oncology
https://www.readbyqxmd.com/read/29185273/trends-of-low-grade-serous-ovarian-carcinoma-in-the-united-states
#20
Koji Matsuo, Hiroko Machida, Brendan H Grubbs, Anil K Sood, David M Gershenson
No abstract text is available yet for this article.
January 2018: Journal of Gynecologic Oncology
journal
journal
42137
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"